Private Asset Management Raised Gilead Sciences (GILD) Stake; Air Products & Chemicals (APD) Has 1.31 Sentiment

Private Asset Management Inc increased Gilead Sciences Inc. (GILD) stake by 19.82% reported in 2017Q3 SEC filing. Private Asset Management Inc acquired 23,555 shares as Gilead Sciences Inc. (GILD)’s stock declined 8.05%. The Private Asset Management Inc holds 142,405 shares with $11.54M value, up from 118,850 last quarter. Gilead Sciences Inc. now has $111.63 billion valuation. The stock increased 5.26% or $4.27 during the last trading session, reaching $85.46. About 14.62 million shares traded or 79.43% up from the average. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since January 27, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, electronics and performance materials, equipment, and services worldwide. The company has market cap of $37.17 billion. The firm produces atmospheric gases, including oxygen, nitrogen, argon, and rare gases; process gases, such as hydrogen, helium, carbon dioxide, carbon monoxide, syngas, and specialty gases; and equipment for the production or processing of gases comprising air separation units and non-cryogenic generators for clients in various industries, including metals, glass, chemical processing, electronics, energy production and refining, food processing, metallurgical, medical, and general manufacturing. It has a 12.44 P/E ratio. It also creates and makes equipment for air separation, hydrocarbon recovery and purification, natural gas liquefaction, and liquid helium and liquid hydrogen transport and storage.

The stock decreased 2.39% or $4.15 during the last trading session, reaching $169.85. About 2.70 million shares traded or 192.44% up from the average. Air Products and Chemicals, Inc. (APD) has risen 9.23% since January 27, 2017 and is uptrending. It has underperformed by 7.47% the S&P500.

Freshford Capital Management Llc holds 8.23% of its portfolio in Air Products and Chemicals, Inc. for 262,765 shares. Glenhill Advisors Llc owns 573,671 shares or 7.03% of their US portfolio. Moreover, Talara Capital Management Llc has 6.97% invested in the company for 88,702 shares. The New York-based Axel Capital Management Llc has invested 6.76% in the stock. Banbury Partners Llc, a North Carolina-based fund reported 147,488 shares.

Private Asset Management Inc decreased Merck & Co Inc (NYSE:MRK) stake by 9,032 shares to 233,953 valued at $14.98M in 2017Q3. It also reduced Novartis Ag (NYSE:NVS) stake by 8,764 shares and now owns 77,371 shares. Oracle Corporation (NYSE:ORCL) was reduced too.

Since August 1, 2017, it had 0 insider purchases, and 13 selling transactions for $51.52 million activity. Another trade for 15,000 shares valued at $1.14M was sold by Alton Gregg H. Another trade for 50,000 shares valued at $3.68M was sold by MARTIN JOHN C. Meyers James R sold $4.99M worth of stock or 60,000 shares. Another trade for 51,820 shares valued at $4.40 million was sold by Washington Robin L.

Investors sentiment increased to 1.03 in 2017 Q3. Its up 0.10, from 0.93 in 2017Q2. It is positive, as 96 investors sold GILD shares while 488 reduced holdings. 127 funds opened positions while 474 raised stakes. 957.62 million shares or 2.06% more from 938.32 million shares in 2017Q2 were reported. Columbia Partners L L C Mngmt reported 0.03% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Deutsche Retail Bank Ag accumulated 10.84 million shares or 0.6% of the stock. 20,200 were accumulated by Tb Alternative Assets. 45,552 were reported by Wright Investors Ser. Indiana Tru Mngmt holds 0.5% or 12,922 shares in its portfolio. Ngam Limited Partnership reported 0.13% stake. Smith Chas P & Pa Cpas holds 0.03% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 3,019 shares. 9,023 were accumulated by Hollencrest Secs Limited Liability Com. Manufacturers Life Co The holds 5.44 million shares or 0.53% of its portfolio. 57,382 were accumulated by Jolley Asset Mngmt Ltd Liability Corp. Narwhal Cap Management has 39,330 shares for 0.79% of their portfolio. Pekin Singer Strauss Asset Il owns 14,909 shares. Nippon Life holds 0.12% in Gilead Sciences, Inc. (NASDAQ:GILD) or 82,129 shares. Kistler owns 8,482 shares or 0.29% of their US portfolio. Pinnacle Wealth Management Advisory Grp Ltd Limited Liability Company owns 5,213 shares for 0.25% of their portfolio.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 20 have Buy rating, 0 Sell and 10 Hold. Therefore 67% are positive. Gilead Sciences has $137 highest and $7200 lowest target. $97.27’s average target is 13.82% above currents $85.46 stock price. Gilead Sciences had 113 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, February 3 by Standpoint Research. Jyske Bank upgraded the stock to “Strong Buy” rating in Thursday, September 10 report. As per Tuesday, July 26, the company rating was downgraded by Needham. The firm earned “Buy” rating on Wednesday, October 18 by Cowen & Co. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Outperform” rating given on Wednesday, November 2 by RBC Capital Markets. Credit Suisse downgraded Gilead Sciences, Inc. (NASDAQ:GILD) on Wednesday, December 20 to “Neutral” rating. As per Monday, August 28, the company rating was maintained by Maxim Group. Leerink Swann downgraded Gilead Sciences, Inc. (NASDAQ:GILD) on Tuesday, September 27 to “Mkt Perform” rating. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Buy” rating given on Friday, January 26 by Jefferies. The rating was maintained by Cowen & Co on Tuesday, July 25 with “Buy”.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: